➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Baxter
Colorcon
Harvard Business School
AstraZeneca

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

VECURONIUM BROMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Vecuronium Bromide, and when can generic versions of Vecuronium Bromide launch?

Vecuronium Bromide is a drug marketed by Aurobindo Pharma Ltd, Gland Pharma Ltd, Hikma, Hospira, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, Teva Pharms Usa, Watson Labs, and West-ward Pharms Int. and is included in twelve NDAs.

The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.

US ANDA Litigation and Generic Entry Outlook for Vecuronium Bromide

A generic version of VECURONIUM BROMIDE was approved as vecuronium bromide by TEVA PHARMS USA on August 25th, 1999.

  Start Trial

Drug patent expirations by year for VECURONIUM BROMIDE
Recent Clinical Trials for VECURONIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 2/Phase 3
Merck Sharp & Dohme Corp.Phase 4
Maine Medical CenterPhase 4

See all VECURONIUM BROMIDE clinical trials

Pharmacology for VECURONIUM BROMIDE
Medical Subject Heading (MeSH) Categories for VECURONIUM BROMIDE
Paragraph IV (Patent) Challenges for VECURONIUM BROMIDE
Tradename Dosage Ingredient NDA Submissiondate
NORCURON INJECTABLE;INJECTION vecuronium bromide 018776

US Patents and Regulatory Information for VECURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 206670-001 Dec 20, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Watson Labs VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 074334-001 Aug 31, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 075558-001 Sep 11, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 205390-002 May 26, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 078274-001 Dec 29, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int VECURONIUM BROMIDE vecuronium bromide INJECTABLE;INJECTION 075218-001 Aug 23, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
McKinsey
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.